Market Size Estimation 2.4.1
Sex-associated molecular differences for cancer immunotherapy
Therefore, EC and CH were marked as potential inhibitors of the murine tyrosinase enzyme by comparison to C3G
Refsum H, Nurk E, Smith AD, et al
Hn hp enzyme c tc dng h tr chc nng ca h thng tiu ho, gip phn gii thc n d dng hn, lm gim cc triu chng chng bng, y hi, kh tiu
Middle East and Africa Clinical Trials Market Driven by Rising Chronic Diseases and Research Investments The Middle East and Africa clinical trials market was valued at US$ 2.81 billion in 2025 and is expected to reach US$ 3.03 billion in 2026, progressing steadily to approximately US$ 5.79 billion by 2035